Visfatin and
apelin are two novel adipocyte- secreted
hormone proposed to link
obesity with
insulin resistance. In this study we investigated whether plasma
visfatin and
apelin levels were altered in normal,
impaired glucose tolerance, and type 2 diabetic subjects. We also assessed the association between plasma
visfatin, or
apelin and body composition, metabolic parameters, and
resistin concentrations in these subjects. The
visfatin levels of fasting and 2-h post-
glucose load were found to be significantly decreased in diabetics compared with the controls ( P<0.05). In contrast, basal
apelin levels were significantly increased in the IGT and diabetic subjects compared with the controls ( P<0.05 and P<0.01). The
apelin levels of 2-h post-
glucose load were significantly higher than the basal levels in every group (all P<0.05). Fasting plasma
visfatin was found to correlate positively and significantly with BMI, WHR, and fasting plasma
resistin, but negatively with HbA1c and 2 h OGTT
glucose. Multiple regression analysis showed that WHR, HbA1c, 2 h OGTT
glucose were independent related factors influencing plasma
visfatin levels. Fasting plasma
apelin levels correlated positively with HOMA-IR, BMI, TC,
LDL-C, FBG and Fasting plasma
insulin. Multiple regression analysis also showed that HOMA-IR, BMI, and TC were independent related factors influencing plasma
apelin levels. The present work indicates the potential link of
visfatin and
apelin with the pathogenesis of
insulin resistance and T2DM.